$1000 Invested In Descartes Systems Group 10 Years Ago Would Be Worth This Much Today - Descartes Systems Group ( NASDAQ:DSGX )
Descartes Systems Group DSGX has outperformed the market over the past 10 years by 10.38% on an annualized basis producing an average annual return of 20.77%. Currently, Descartes Systems Group has a market capitalization of $8.54 billion.
Adobe Q1 Earnings: Revenue Beat, EPS Beat, Reaffirmed FY Guidance And More - Adobe ( NASDAQ:ADBE )
Adobe reports first-quarter revenue of $5.71 billion, beating the consensus estimate of $5.66 billion. Adobe reports first-quarter adjusted earnings of $5.08 per share, beating analyst estimates of $4.97 per share.
Bitcoin, Ethereum Slip, XRP, Dogecoin Hold Gains On Slow Wednesday
Global cryptocurrency market capitalization is trading 2.1% higher to $2.7 trillion. Traders remain divided-some see a bearish setup, while others believe the bull run is yet to start. The new Benzinga Rankings show you exactly how stocks stack up-scoring them across five key factors that matter ...
Bird Announces 2024 Fourth Quarter and Annual Results; Delivers $0.6B Revenue Growth, 6.3% ADJ. EBITDA Margin, and Affirms 2025-2027 Strategic Plan Targets
MISSISSAUGA, Ontario, March 12, 2025 ( GLOBE NEWSWIRE ) -- "Bird's exceptional revenue and profitability growth in 2024, delivering almost $600 million of additional revenue while increasing our Adjusted EBITDA Margin by 1.3% to 6.3%, is the direct result of strategic changes we've made over the ...
UiPath Shares Plunge After Q4 Revenues Miss, Weak Q1 Guidance - UiPath ( NYSE:PATH )
UiPath reports quarterly earnings of 9 cents per share which beat the analyst consensus estimate of 3 cents. Quarterly revenue of $424 million misses the analyst consensus estimate of $425.36 million. Find out which stock just claimed the top spot in the new Benzinga Rankings.
SCYNEXIS Reports Full Year 2024 Financial Results and Provides Corporate Update
JERSEY CITY, N.J., March 12, 2025 ( GLOBE NEWSWIRE ) -- SCYNEXIS, Inc. ( NASDAQ: SCYX ) , a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the year ended December 31, 2024.
Jamie Dimon Warns Of Economic Weakening, Negative Consumer Sentiment - JPMorgan Chase ( NYSE:JPM )
JPMorgan CEO Jamie Dimon warns that he sees a weakening of the economy and negative sentiment. Dimon notes that he doesn't believe the average American "changes what they're going to do" because of tariffs.
Analyst Sees Bottom For Myriad Genetics Stock, Issues Upgrade - Myriad Genetics ( NASDAQ:MYGN )
Piper Sandler upgrades Myriad Genetics to Overweight, raising the price target to $12.50 from $11.50. Myriad Genetics plans to launch a new AI-integrated prostate test later this year or early next year. Find out which stock just plummeted to the bottom of the new Benzinga Rankings.
Crypto exchange OKX secures MiFID II license in Europe
Cryptocurrency exchange OKX has acquired a key European Union license that will enable the company to offer derivatives products throughout the region, potentially opening the door to a more advanced segment of the trading community.
Mustang Energy Corp. Provides Corporate Updates
VANCOUVER, British Columbia, March 12, 2025 ( GLOBE NEWSWIRE ) -- Mustang Energy Corp. ( CSE: MEC, OTC: MECPF, FRA:92T ) ( the "Company" or "Mustang" ) is pleased to provide a comprehensive overview of its significant milestones and achievements throughout 2025, underscoring the Company's ...




